123330 — Genic Co Balance Sheet
0.000.00%
- KR₩189bn
- KR₩179bn
- KR₩78bn
Annual balance sheet for Genic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17,193 | 5,889 | 1,673 | 1,290 | 13,247 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,917 | 3,487 | 3,375 | 12,479 | 6,218 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 29,541 | 15,452 | 9,447 | 20,827 | 30,897 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 15,278 | 14,370 | 13,635 | 14,960 | 18,250 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 45,411 | 30,356 | 23,402 | 38,157 | 56,533 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15,700 | 14,254 | 11,699 | 15,277 | 13,021 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26,113 | 14,413 | 11,870 | 16,003 | 15,486 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 19,297 | 15,943 | 11,531 | 22,154 | 41,048 |
| Total Liabilities & Shareholders' Equity | 45,411 | 30,356 | 23,402 | 38,157 | 56,533 |
| Total Common Shares Outstanding |